135 related articles for article (PubMed ID: 3858983)
1. Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia.
Bratt G; Blombäck M; Paul C; Schulman S; Törnebohm E; Lockner D
Scand J Haematol; 1985 Apr; 34(4):332-9. PubMed ID: 3858983
[TBL] [Abstract][Full Text] [Related]
2. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
[TBL] [Abstract][Full Text] [Related]
3. Bleeding complications and coagulopathy in acute leukaemia.
Törnebohm E; Blombäck M; Lockner D; Egberg N; Paul C
Leuk Res; 1992 Oct; 16(10):1041-8. PubMed ID: 1405706
[TBL] [Abstract][Full Text] [Related]
4. A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia.
Sureda A; García Frade LJ; Torrado MC; García Laraña J; García Avello A
Acta Haematol; 1992; 88(2-3):100-4. PubMed ID: 1281598
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation and fibrinolysis in acute leukaemia.
Brakman P; Snyder J; Henderson ES; Astrup T
Br J Haematol; 1970 Feb; 18(2):135-45. PubMed ID: 4245344
[No Abstract] [Full Text] [Related]
6. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
Velasco F; Torres A; Andres P; Martinez F; Gomez P
Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
[TBL] [Abstract][Full Text] [Related]
8. [Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
Génova V; Georgief Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):300-12. PubMed ID: 4136341
[No Abstract] [Full Text] [Related]
9. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.
Hellgren M; Egberg N; Eklund J
Intensive Care Med; 1984; 10(1):23-8. PubMed ID: 6559831
[TBL] [Abstract][Full Text] [Related]
11. Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.
Pabinger I; Bettelheim P; Dudczak R; Hinterberger W; Kyrle PA; Niessner H; Schwarzinger I; Speiser W; Lechner K
Ann Hematol; 1991 May; 62(5):174-9. PubMed ID: 2049464
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
13. Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.
Sakuragawa N; Takahashi K; Hoshiyama M; Jimbo C; Matsuoka M
Thromb Res; 1976 Mar; 8(3):263-73. PubMed ID: 1083568
[No Abstract] [Full Text] [Related]
14. Blood coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, southern Brazil.
Zannin M; Lourenço DM; Motta G; Dalla Costa LR; Grando M; Gamborgi GP; Noguti MA; Chudzinski-Tavassi AM
Thromb Haemost; 2003 Feb; 89(2):355-64. PubMed ID: 12574817
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].
Dreyfus B; Varet B; Heilmann-Gouault M; Sultan C; Reyes F; Gluckman E; Basch A; Beaujean F
Nouv Rev Fr Hematol; 1973; 13(6):761-70. PubMed ID: 4280042
[No Abstract] [Full Text] [Related]
16. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
von Kries R; Ebell W; Jürgens H; Göbel U
Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
[TBL] [Abstract][Full Text] [Related]
17. [Disseminated intravascular coagulation (D.I.C.) and fibrinolysis in patients with acute leukemia (author's transl)].
Bunjevacki G; Sultan Y; Izraël V
Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):575-84. PubMed ID: 286287
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
[TBL] [Abstract][Full Text] [Related]
19. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis and pathologic physiology of disseminated intravascular coaguration (DIC) in patients with acute promyelocytic leukemia (author's transl)].
Ando Y; Watanabe K
Rinsho Ketsueki; 1976 Apr; 17(4):389-95. PubMed ID: 1066493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
